Literature DB >> 10947215

Validation of a diagnosis model for differentiating bacterial from viral meningitis in infants and children under 3.5 years of age.

F Jaeger1, J Leroy, F Duchêne, V Baty, S Baillet, J M Estavoyer, B Hoen.   

Abstract

The aim of this study was to validate, in a population of infants and children under 3.5 years of age, a diagnosis model that provides a figure for the probability of bacterial meningitis (pABM), based on four parameters collected at the time of the first lumbar tap: the cerebrospinal fluid (CSF) protein level, CSF polymorphonuclear cell count, blood glucose level, and leucocyte count. The best cut-off value for distinguishing between bacterial and viral meningitis was previously found to be 0.1, since 99% of meningitides associated with pABM<0.1 were viral. The charts of 103 consecutive children aged 0.1-3.5 years who had been hospitalised for acute meningitis were reviewed. Each case was sorted into the following three categories for aetiology: bacterial (positive CSF culture, n=48); viral (negative CSF culture and no other aetiology, and no antibiotic treatment after diagnosis, n=36); and undetermined (fitting neither of the first two definitions, n=19). After computation of pABM values in each case, the predictive values of the model were calculated for different pABM cut-off values. The results confirmed that the best cut-off pABM value was 0.1, for which the positive and negative predictive values in this model were 96% and 97%, respectively. Only one case of bacterial meningitis (lumbar tap performed early in an infant with meningococcal purpura fulminans with negative CSF culture) was associated with a pABM value of <0.1. This model is quite reliable for differentiating between bacterial and viral meningitis in children under 3.5 years of age, and it may enable physicians to withhold antibiotics in cases of meningitis of uncertain aetiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947215     DOI: 10.1007/s100960000292

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach.

Authors:  François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

3.  How to differentiate bacterial from viral meningitis.

Authors:  Werner Zimmerli
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

4.  Cerebrospinal Fluid Findings Are Poor Predictors of Appropriate FilmArray Meningitis/Encephalitis Panel Utilization in Pediatric Patients.

Authors:  Mimi R Precit; Rebecca Yee; Utsav Pandey; Margil Fahit; Cheryl Pool; Samia N Naccache; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

5.  Clinical decision rules to distinguish between bacterial and aseptic meningitis.

Authors:  F Dubos; B Lamotte; F Bibi-Triki; F Moulin; J Raymond; D Gendrel; G Bréart; M Chalumeau
Journal:  Arch Dis Child       Date:  2006-04-04       Impact factor: 3.791

6.  Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis.

Authors:  Alain Viallon; Nicolas Desseigne; Olivier Marjollet; Albert Birynczyk; Mathieu Belin; Stephane Guyomarch; Jacques Borg; Bruno Pozetto; Jean Claude Bertrand; Fabrice Zeni
Journal:  Crit Care       Date:  2011-06-06       Impact factor: 9.097

7.  Performance of thirteen clinical rules to distinguish bacterial and presumed viral meningitis in Vietnamese children.

Authors:  Nguyen Tien Huy; Nguyen Thanh Hong Thao; Nguyen Anh Tuan; Nguyen Tuan Khiem; Christopher C Moore; Doan Thi Ngoc Diep; Kenji Hirayama
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.